Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling
暂无分享,去创建一个
Roland Eils | Benedikt Brors | Holger Christiansen | Jürgen Eils | Patrick Warnat | Alexander Schramm | Patrick Warnat | R. Eils | B. Brors | L. Klein-Hitpass | J. Schulte | A. Eggert | J. Eils | A. Schramm | W. Havers | H. Christiansen | Angelika Eggert | Ludger Klein-Hitpass | Johannes H Schulte | Bernd Berwanger | Hauke Sieverts | H. Sieverts | B. Berwanger | Werner Havers
[1] Holger Christiansen,et al. Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma. , 2002, Cancer cell.
[2] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[3] K K Matthay,et al. Molecular biology of neuroblastoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] J. Ioannidis,et al. Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment , 2003, The Lancet.
[5] R. Hanada,et al. Spontaneous regression of localized neuroblastoma detected by mass screening. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] J. Shay,et al. Differential gene expression profiles between neuroblastomas with high telomerase activity and low telomerase activity. , 2003, Journal of pediatric surgery.
[7] H. Varmus,et al. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. , 1984, Science.
[8] T. Poggio,et al. Prediction of central nervous system embryonal tumour outcome based on gene expression , 2002, Nature.
[9] F. Berthold,et al. Neuroblastoma screening at one year of age. , 2002, The New England journal of medicine.
[10] R. Eils,et al. Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[11] R. Tibshirani,et al. Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[12] Yudong D. He,et al. A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .
[13] F. Speleman,et al. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. , 1999, The New England journal of medicine.
[14] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[15] Rogier Versteeg,et al. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2 , 2002, Oncogene.
[16] M. Radmacher,et al. Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. , 2003, Journal of the National Cancer Institute.
[17] Alberto Maria Segre,et al. Programs for Machine Learning , 1994 .
[18] Ian H. Witten,et al. Data mining: practical machine learning tools and techniques, 3rd Edition , 1999 .
[19] Wan Ariffin Bin Abdullah,et al. Med Pediatr Oncol , 1999 .
[20] K K Matthay,et al. Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid , 1999 .
[21] S. Ishii,et al. Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas. , 2005, Cancer cell.
[22] S. Sugano,et al. Expression profiling and characterization of 4200 genes cloned from primary neuroblastomas: identification of 305 genes differentially expressed between favorable and unfavorable subsets , 2003, Oncogene.
[23] F. Berthold,et al. Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. , 1993, Progress in clinical and biological research.
[24] M. Kok,et al. CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system , 2003, Oncogene.
[25] E. Hiyama,et al. Expression profiling of favorable and unfavorable neuroblastomas , 2003, Pediatric Surgery International.
[26] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.